Profil
Pierre Detrixhe is currently a Non-Executive Director at Bioxodes SA, a Director at Agricells SA, a Partner at Investsud SA, and an Investment Partner at Newton Biocapital Partners SPRL.
He was formerly a Director at ProGenosis SA.
Postes actifs de Pierre Detrixhe
| Sociétés | Poste | Début |
|---|---|---|
Investsud SA
 Investsud SA Investment ManagersFinance INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium. | Private Equity Investor | 01/01/2007 |
Bioxodes SA
 Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Directeur/Membre du Conseil | - |
Newton Biocapital Partners SRL
 Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Private Equity Investor | - |
Agricells SA
 Agricells SA BiotechnologyHealth Technology Agricells SA is a Belgian company that specializes in research and development for agriculture using biosolutions such as biocontrol, biostimulant, and biofertilizer. The company is based in Marche-en-Famenne, Belgium. The company focuses on innovation, greentech, and biotechnologies in the field of agriculture. Agricells was founded in 2020 by Maxence Semacoy Albertini and Vincent Vandamme, with Maxence Semacoy Albertini serving as the CEO since 2020. | Directeur/Membre du Conseil | 06/12/2020 |
Anciens postes connus de Pierre Detrixhe
| Sociétés | Poste | Fin |
|---|---|---|
ProGenosis SA
 ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Investsud SA
Investsud SA Investment ManagersFinance INVESTSUD SA (INVESTSUD) is an independent venture capital firm founded in 1983. Investsud SA is headquartered in Marche-en-Famenne, Belgium. | Finance |
ProGenosis SA
ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
Bioxodes SA
Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Health Technology |
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Finance |
Agricells SA
Agricells SA BiotechnologyHealth Technology Agricells SA is a Belgian company that specializes in research and development for agriculture using biosolutions such as biocontrol, biostimulant, and biofertilizer. The company is based in Marche-en-Famenne, Belgium. The company focuses on innovation, greentech, and biotechnologies in the field of agriculture. Agricells was founded in 2020 by Maxence Semacoy Albertini and Vincent Vandamme, with Maxence Semacoy Albertini serving as the CEO since 2020. | Health Technology |
